{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:35:26Z","timestamp":1778200526538,"version":"3.51.4"},"reference-count":96,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jaip.2021.05.038","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T18:18:22Z","timestamp":1623953902000},"page":"3911-3917","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["The Revenge of Unintended Consequences of Anaphylaxis-Risk Overdiagnosis: How Far We Have Come and How Far We Have to Go"],"prefix":"10.1016","volume":"9","author":[{"given":"Elissa M.","family":"Abrams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Greenhawt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waleed","family":"Alqurashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander G.","family":"Singer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2021.05.038_bib1","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/j.jaci.2009.12.981","article-title":"Anaphylaxis","volume":"125","author":"Simons","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2010.10.008","article-title":"Guidelines for the Diagnosis and Management of Food Allergy in the United States: report of the NIAID-sponsored expert panel","volume":"126","author":"Boyce","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib3","doi-asserted-by":"crossref","first-page":"100066","DOI":"10.1016\/j.waojou.2019.100066","article-title":"Time to revisit the definition and clinical criteria for anaphylaxis?","volume":"12","author":"Turner","year":"2019","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2021.05.038_bib4","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S1081-1206(10)61086-1","article-title":"Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma, and Immunology Epidemiology of Anaphylaxis Working Group","volume":"97","author":"Lieberman","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jaci.2013.08.016","article-title":"Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United States","volume":"133","author":"Wood","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib6","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaci.2020.01.017","article-title":"Anaphylaxis\u2014a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis","volume":"145","author":"Shaker","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13223-018-0283-4","article-title":"Anaphylaxis","volume":"14","author":"Fischer","year":"2018","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib8","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/archpedi.155.7.790","article-title":"Food-allergic reactions in schools and preschools","volume":"155","author":"Nowak-Wegrzyn","year":"2001","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jaip.2021.05.038_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2014.08.018","article-title":"Fatal anaphylaxis in the United States, 1999-2010: temporal patterns and demographic associations","volume":"134","author":"Jerschow","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib10","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/cea.12211","article-title":"Incidence of fatal food anaphylaxis in people with food allergy: a systematic review and meta-analysis","volume":"43","author":"Umasunthar","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2021.05.038_bib11","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaip.2017.06.031","article-title":"Fatal anaphylaxis: mortality rate and risk factors","volume":"5","author":"Turner","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.05.038_bib12","first-page":"654","article-title":"Overdiagnosis: causes and consequences in primary health care","volume":"64","author":"Singh","year":"2018","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.jaip.2021.05.038_bib13","doi-asserted-by":"crossref","first-page":"k2820","DOI":"10.1136\/bmj.k2820","article-title":"Overdiagnosis in primary care: framing the problem and finding solutions","volume":"362","author":"Kale","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2021.05.038_bib14","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/all.13446","article-title":"\u201cTo screen or not to screen\u201d: comparing the health and economic benefits of early peanut introduction strategies in five countries","volume":"73","author":"Shaker","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.05.038_bib15","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jaip.2021.01.022","article-title":"The COVID-19 pandemic in 2021: avoiding overdiagnosis of anaphylaxis risk while safely vaccinating the world","volume":"9","author":"Greenhawt","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.05.038_bib16","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1111\/all.13565","article-title":"The health and economic outcomes of early egg introduction strategies","volume":"73","author":"Shaker","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.05.038_bib17","doi-asserted-by":"crossref","first-page":"e1918041","DOI":"10.1001\/jamanetworkopen.2019.18041","article-title":"Determining levers of cost-effectiveness for screening infants at high risk for peanut sensitization before early peanut introduction","volume":"2","author":"Greenhawt","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaip.2021.05.038_bib18","article-title":"Optimizing value in the evaluation of chronic spontaneous urticaria: a cost-effectiveness analysis","volume":"8","author":"Shaker","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.05.038_bib19","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S2352-4642(20)30029-8","article-title":"Pros and cons of pre-emptive screening programmes before peanut introduction in infancy","volume":"4","author":"Abrams","year":"2020","journal-title":"Lancet Child Adolesc Heal"},{"key":"10.1016\/j.jaip.2021.05.038_bib20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/MOP.0000000000000879","article-title":"Update on penicillin allergy delabeling","volume":"32","author":"Shaker","year":"2020","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.jaip.2021.05.038_bib21","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/MOP.0b013e32834ac7a3","article-title":"An update on influenza vaccination in patients with egg allergy","volume":"23","author":"Gruenberg","year":"2011","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.jaip.2021.05.038_bib22","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/cea.13443","article-title":"Should testing be initiated prior to amoxicillin challenge in children?","volume":"49","author":"Abrams","year":"2019","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2021.05.038_bib23","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jaip.2018.11.052","article-title":"Delabeling penicillin allergy: is skin testing required at all?","volume":"7","author":"Abrams","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.05.038_bib24","series-title":"Why Things Bite Back: Technology and the Revenge of Unintended Consequences","author":"Tenner","year":"1996"},{"key":"10.1016\/j.jaip.2021.05.038_bib25","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMoa1414850","article-title":"Randomized trial of peanut consumption in infants at risk for peanut allergy","volume":"372","author":"Du Toit","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.05.038_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaci.2016.10.010","article-title":"Addendum guidelines for the prevention of peanut allergy in the United States: report of the National Institute of Allergy and Infectious Diseases\u2013sponsored expert panel","volume":"139","author":"Togias","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib27","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1016\/j.jaip.2020.08.044","article-title":"Increasing awareness of the low risk of severe reaction at infant peanut introduction: implications during COVID-19 and beyond","volume":"8","author":"Abrams","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.05.038_bib29","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S1081-1206(10)60220-7","article-title":"Pearls and pitfalls of allergy diagnostic testing: report from the American College of Allergy, Asthma, and Immunology\/American Academy of Allergy, Asthma, and Immunology Specific IgE Test Task Force","volume":"101","author":"Cox","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.iac.2014.09.009","article-title":"Optimizing the diagnosis of food allergy","volume":"35","author":"Kattan","year":"2015","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2021.05.038_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2016.04.011","article-title":"Understanding the feasibility and implications of implementing early peanut introduction for prevention of peanut allergy","volume":"138","author":"Koplin","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib32","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1016\/j.jaip.2019.04.044","article-title":"Comparison of practice patterns among Canadian allergists before and after NIAID guideline recommendations","volume":"7","author":"Abrams","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.05.038_bib33","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jpeds.2017.12.011","article-title":"Potential pitfalls in applying screening criteria in infants at risk of peanut allergy","volume":"195","author":"Abrams","year":"2018","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jaip.2021.05.038_bib34","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1001\/jama.2017.0922","article-title":"Implementing primary prevention for peanut allergy at a population level","volume":"317","author":"Turner","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2021.05.038_bib35","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jaci.2020.07.031","article-title":"Peanut allergy diagnosis: a 2020 practice parameter update, systematic review, and GRADE analysis","volume":"146","author":"Greenhawt","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib36","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jaci.2020.11.034","article-title":"Ara h 2-specific IgE is superior to whole peanut extract\u2013based serology or skin prick test for diagnosis of peanut allergy in infancy","volume":"147","author":"Keet","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib37","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jaci.2021.03.014","article-title":"Leveraging shared decision making to discuss nonessential medical testing and prevent peanut allergy overdiangosis during infancy","volume":"148","author":"Greenhawt","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2020.11.033","article-title":"Age and eczema severity, but not family history, are major risk factors for peanut allergy in infancy","volume":"147","author":"Keet","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib39","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jaip.2020.11.002","article-title":"A\u00a0consensus approach to the primary prevention of food allergy through nutrition: guidance from the American Academy of Allergy, Asthma, and Immunology; American College of Allergy, Asthma, and Immunology; and the Canadian Society for Allergy and Clinica","volume":"9","author":"Fleischer","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.05.038_bib40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.anai.2010.08.002","article-title":"Drug allergy: an updated practice parameter","volume":"105","author":"Weiss","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib41","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/pai.12155","article-title":"Diagnostic evaluation of hypersensitivity reactions to beta-lactam antibiotics in a large population of children","volume":"25","author":"Zambonino","year":"2014","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.anai.2018.05.013","article-title":"Prospective assessment of diagnostic tests for pediatric penicillin allergy: from clinical history to challenge tests","volume":"121","author":"Ibanez","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib43","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jpeds.2018.09.035","article-title":"The importance of delabeling \u03b2-lactam allergy in children","volume":"204","author":"Abrams","year":"2019","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jaip.2021.05.038_bib44","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)17907-0","article-title":"Outpatient antibiotic use in Europe and association with resistance: a cross-national database study","volume":"365","author":"Goossens","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2021.05.038_bib45","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaci.2013.09.021","article-title":"Health care use and serious infection prevalence associated with penicillin \u201callergy\u201d in hospitalized patients: a cohort study","volume":"133","author":"Macy","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib46","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jhm.2036","article-title":"The\u00a0impact of penicillin skin testing on clinical practice and antimicrobial stewardship","volume":"8","author":"Rimawi","year":"2013","journal-title":"J\u00a0Hosp Med"},{"key":"10.1016\/j.jaip.2021.05.038_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2019.09.017","article-title":"A\u00a0closer look at penicillin allergy history: systematic review and meta-analysis of tolerance to drug challenge","volume":"133","author":"DesBiens","year":"2020","journal-title":"Am J Med"},{"key":"10.1016\/j.jaip.2021.05.038_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamapediatrics.2016.0033","article-title":"Assessing the diagnostic properties of a graded oral provocation challenge for the diagnosis of immediate and nonimmediate reactions to amoxicillin in children","volume":"170","author":"Mill","year":"2016","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jaip.2021.05.038_bib49","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.anai.2014.02.005","article-title":"Penicillin and cephalosporin allergy","volume":"112","author":"Pichichero","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib50","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.annemergmed.2015.03.003","article-title":"Emergency department corticosteroid use for allergy or anaphylaxis is not associated with decreased relapses","volume":"66","author":"Grunau","year":"2015","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jaip.2021.05.038_bib51","article-title":"Time of onset and predictors of biphasic anaphylactic reactions: a systematic review and meta-analysis","volume":"3","author":"Lee","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.05.038_bib52","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.jaip.2017.05.022","article-title":"Do corticosteroids prevent biphasic anaphylaxis?","volume":"5","author":"Alqurashi","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.05.038_bib53","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jpeds.2015.05.033","article-title":"Glucocorticoids and hospital length of stay for children with anaphylaxis: a retrospective study","volume":"167","author":"Michelson","year":"2015","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jaip.2021.05.038_bib54","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/archdischild-2015-309522","article-title":"Systematic review of the toxicity of short-course oral corticosteroids in children","volume":"101","author":"Aljebab","year":"2016","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jaip.2021.05.038_bib55","article-title":"Evaluation of prehospital management in a Canadian emergency department anaphylaxis cohort","volume":"7","author":"Gabrielli","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.05.038_bib56","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.anai.2015.07.019","article-title":"Anaphylaxis\u2014a practice parameter update 2015","volume":"115","author":"Lieberman","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib57","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40413-015-0080-1","article-title":"2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines","volume":"8","author":"Simons","year":"2015","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2021.05.038_bib58","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1016\/j.jaip.2020.07.020","article-title":"Novel approaches to food allergy management during COVID-19 inspire long-term change","volume":"8","author":"Mack","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.05.038_bib59","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jaip.2017.07.020","article-title":"Further evaluation of factors that may predict biphasic reactions in emergency department anaphylaxis patients","volume":"5","author":"Lee","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.05.038_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.anai.2015.05.013","article-title":"Epidemiology and clinical predictors of biphasic reactions in children with anaphylaxis","volume":"115","author":"Alqurashi","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib61","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1542\/peds.106.4.762","article-title":"Biphasic anaphylactic reactions in pediatrics","volume":"106","author":"Lee","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2021.05.038_bib62","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2332\/allergolint.10-OA-0256","article-title":"Anaphylaxis and biphasic phase in Thailand: 4-year observation","volume":"60","author":"Lertnawapan","year":"2011","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2021.05.038_bib63","first-page":"281","article-title":"Pediatric anaphylaxis: triggers, clinical features, and treatment in a tertiary-care hospital","volume":"33","author":"Manuyakorn","year":"2015","journal-title":"Asian Pacific J Allergy Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib64","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/j.1365-2222.2009.03276.x","article-title":"Clinical predictors for biphasic reactions in children presenting with anaphylaxis","volume":"39","author":"Mehr","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2021.05.038_bib65","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.anai.2018.06.035","article-title":"An economic evaluation of immediate vs non-immediate activation of emergency medical services after epinephrine use for peanut-induced anaphylaxis","volume":"122","author":"Shaker","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib66","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.jaip.2020.04.022","article-title":"Acute at home management of anaphylaxis during the Covid-19 pandemic","volume":"8","author":"Casale","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.05.038_bib67","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.jaip.2020.05.012","article-title":"A\u00a0phased approach to resuming suspended allergy\/immunology clinical services","volume":"8","author":"Searing","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.05.038_bib69","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.05.038_bib70","doi-asserted-by":"crossref","first-page":"m4780","DOI":"10.1136\/bmj.m4780","article-title":"Covid-19: people with history of significant allergic reactions should not receive Pfizer vaccine, says regulator","volume":"371","author":"Mahase","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2021.05.038_bib71","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13223-021-00529-2","article-title":"COVID-19 vaccine testing and administration guidance for allergists\/immunologists from the Canadian Society of Allergy and Clinical Immunology (CSACI)","volume":"17","author":"Vander Leek","year":"2021","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib73","doi-asserted-by":"crossref","first-page":"e185630","DOI":"10.1001\/jamanetworkopen.2018.5630","article-title":"Prevalence and severity of food allergies among US adults","volume":"2","author":"Gupta","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaip.2021.05.038_bib74","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0091-6749(99)70392-1","article-title":"Epidemiology of anaphylaxis in Olmsted County: a population-based study","volume":"104","author":"Yocum","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2021.02.054","article-title":"A\u00a0cost-effectiveness evaluation of hospitalizations, fatalities, and economic outcomes associated with universal versus anaphylaxis risk\u2013stratified COVID-19 vaccination strategies","volume":"9","author":"Shaker","year":"2021","journal-title":"J Allergy Clin Immunol Pract."},{"key":"10.1016\/j.jaip.2021.05.038_bib76","first-page":"1","article-title":"COVID-19 Response Team Food and Drug Administration. Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine\u2014United States, December 14-23","volume":"6","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaip.2021.05.038_bib77","doi-asserted-by":"crossref","first-page":"j570","DOI":"10.1136\/bmj.j570","article-title":"Eliminating waste in healthcare spending","volume":"356","author":"Chalkidou","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2021.05.038_bib78","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.anai.2020.04.007","article-title":"Achieving the quadruple aim to deliver value-based allergy care in an ever-evolving health care system","volume":"125","author":"Iglesia","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib79","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.anai.2020.05.029","article-title":"Keeping risk in context while rethinking the setting of asthma biologics in patient-centered care","volume":"125","author":"Greenhawt","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib80","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jaip.2019.09.037","article-title":"Estimation of health and economic benefits of clinic versus home administration of omalizumab and mepolizumab","volume":"8","author":"Shaker","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.05.038_bib81","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.jaip.2020.05.007","article-title":"Health and economic outcomes of home maintenance allergen immunotherapy in select patients with high health literacy during the COVID-19 pandemic: a cost-effectiveness analysis during exceptional times","volume":"8","author":"Shaker","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.05.038_bib82","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.anai.2019.09.009","article-title":"The cost-effectiveness of requiring universal vs contextual self-injectable epinephrine autoinjector for allergen immunotherapy","volume":"123","author":"Sun","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib83","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1016\/j.jaip.2020.07.016","article-title":"Managing food allergy in schools during the COVID-19 pandemic","volume":"8","author":"Greenhawt","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.05.038_bib84","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1016\/j.jaip.2020.05.048","article-title":"Virtually supported home peanut introduction during COVID-19 for at-risk infants","volume":"8","author":"Mack","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.05.038_bib85","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.rcl.2016.10.012","article-title":"The evidence for and against corticosteroid prophylaxis in at-risk patients","volume":"55","author":"Davenport","year":"2017","journal-title":"Radiol Clin North Am"},{"key":"10.1016\/j.jaip.2021.05.038_bib86","doi-asserted-by":"crossref","first-page":"e1913951","DOI":"10.1001\/jamanetworkopen.2019.13951","article-title":"Simulation of health and economic benefits of extended observation of resolved anaphylaxis","volume":"2","author":"Shaker","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaip.2021.05.038_bib87","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S1081-1206(10)60567-4","article-title":"An economic evaluation of prophylactic self-injectable epinephrine to prevent fatalities in children with mild venom anaphylaxis","volume":"99","author":"Shaker","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib88","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.anai.2016.10.031","article-title":"Stinging insect hypersensitivity: a practice parameter update 2016","volume":"118","author":"Golden","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib89","doi-asserted-by":"crossref","first-page":"e184728","DOI":"10.1001\/jamanetworkopen.2018.4728","article-title":"Association of fatality risk with value-based drug pricing of epinephrine autoinjectors for children with peanut allergy: a cost-effectiveness analysis","volume":"1","author":"Shaker","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaip.2021.05.038_bib90","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.anai.2017.05.020","article-title":"Economic evaluation of epinephrine auto-injectors for peanut allergy","volume":"119","author":"Shaker","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib91","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1542\/peds.2007-0731","article-title":"Self-injectable epinephrine for first-aid management of anaphylaxis","volume":"120","author":"Shaker","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2021.05.038_bib92","article-title":"A\u00a0cost-effectiveness analysis of epinephrine autoinjector risk stratification for patients with food allergy\u2014one epinephrine autoinjector or two?","volume":"9","author":"Shaker","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.05.038_bib93","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.jaip.2018.04.036","article-title":"The health and economic outcomes of peanut allergy management practices","volume":"6","author":"Shaker","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.05.038_bib94","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.anai.2020.01.029","article-title":"Engaging patient partners in state of the art allergy care: finding balance when discussing risk","volume":"125","author":"Shaker","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.05.038_bib95","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.jaip.2020.04.012","article-title":"Special article: risk communication during COVID-19","volume":"8","author":"Abrams","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.05.038_bib96","series-title":"Back to the Future. Universal Pictures","author":"Zemeckis","year":"1985"},{"key":"10.1016\/j.jaip.2021.05.038_bib97","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.jaip.2020.07.003","article-title":"The challenges and opportunities for shared decision making highlighted by COVID-19","volume":"8","author":"Abrams","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.05.038_bib98","doi-asserted-by":"crossref","first-page":"e2011535","DOI":"10.1001\/jamanetworkopen.2020.11535","article-title":"Clinician adoption of US peanut introduction guidelines\u2014a case for conditional recommendations and contextual considerations to empower shared decision-making","volume":"3","author":"Shaker","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaip.2021.05.038_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.anai.2020.03.009","article-title":"Making the GRADE in anaphylaxis management: toward recommendations integrating values, preferences, context, and shared decision making","volume":"124","author":"Shaker","year":"2020","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821006668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821006668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:30:55Z","timestamp":1761975055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219821006668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":96,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S2213219821006668"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2021.05.038","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Revenge of Unintended Consequences of Anaphylaxis-Risk Overdiagnosis: How Far We Have Come and How Far We Have to Go","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2021.05.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}